Background Reirradiation using brachytherapy (BT) and external beam radiation therapy
(EBRT) are salvage strategies with locally radiorecurrent prostate cancer. This systematic …

The task group (TG) on magnetic resonance imaging (MRI) implementation in high‐dose‐
rate (HDR) brachytherapy (BT)—Considerations from simulation to treatment, TG 303, was …

Purpose To report the feasibility, toxicity, and preliminary outcomes (metabolic and
biochemical) of 68 Ga-prostate-specific membrane antigen (PSMA) positron emission …

Purpose Radio-recurrent prostate cancer is typically detected by a rising prostate-specific
antigen and may reflect local or distant disease. Positron emission tomography (PET) …

Background Locally recurrent prostate cancer following primary external beam radiotherapy
without distant metastasis is a challenging problem, with no current consensus on the …

Background and purpose Radiorecurrent prostate cancer is often confined to the prostate,
predominantly near the index lesion. The purpose of this study was to look at recurrence …

Abstract Background and Purpose Long-term toxicity of high dose-rate brachytherapy as
monotherapy for prostate cancer is not well defined. We report late toxicity and health …

Purpose/objective To report biochemical control associated with single fraction 15 Gy high-
dose-rate brachytherapy (HDR-BT) boost followed by external beam radiation (EBRT) in …

Simple Summary MRI-guided radiotherapy (MRgRT) is a new technique of radiotherapy. We
evaluated this treatment for the reirradiation of patients with local-only recurrence of prostate …

Although radiotherapy to the prostate for cancer is effective, recurrence occurs in 10–15%
within 5 years. Traditional salvage treatments for men with radiorecurrent prostate cancer …